MedinCell S.A. (MEDCL.PA)

EUR 15.02

(0.47%)

Operating Expenses Summary of MedinCell S.A.

  • MedinCell S.A.'s latest annual operating expenses in 2023 was 32.92 Million EUR , down -8.81% from previous year.
  • MedinCell S.A.'s latest quarterly operating expenses in 2023 FY was 32.88 Million EUR , down -8.81% from previous quarter.
  • MedinCell S.A. reported a annual operating expenses of 36.06 Million EUR in annual operating expenses 2022, up 17.39% from previous year.
  • MedinCell S.A. reported a annual operating expenses of 30.72 Million EUR in annual operating expenses 2021, up 18.72% from previous year.
  • MedinCell S.A. reported a quarterly operating expenses of 16.28 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • MedinCell S.A. reported a quarterly operating expenses of 15.76 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of MedinCell S.A. (2023 - 2015)

Created with Highcharts 11.1.0YearsOperating Expenses2015201620172018201920202021202220230 EUR10000000 EUR20000000 EUR30000000 EUR40000000 EUR

Historical Annual Operating Expenses of MedinCell S.A. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 32.92 Million EUR -8.81%
2022 36.06 Million EUR 17.39%
2021 30.72 Million EUR 18.72%
2020 25.87 Million EUR 7.54%
2019 24.06 Million EUR 50.87%
2018 15.94 Million EUR 17.97%
2017 13.52 Million EUR 30.14%
2016 10.38 Million EUR 33.0%
2015 7.81 Million EUR 0.0%

Peer Operating Expenses Comparison of MedinCell S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -688.174%
ABIVAX Société Anonyme 127.37 Million EUR 74.154%
Adocia SA 15.62 Million EUR -110.647%
Aelis Farma SA 18.81 Million EUR -74.94%
Biophytis S.A. 14.33 Million EUR -129.694%
Advicenne S.A. 8.21 Million EUR -300.755%
genOway Société anonyme 16.73 Million EUR -96.687%
IntegraGen SA 5.35 Million EUR -515.076%
Medesis Pharma S.A. 1.56 Million EUR -2004.218%
Neovacs S.A. 10.34 Million EUR -218.285%
NFL Biosciences SA 4.37 Million EUR -652.614%
Plant Advanced Technologies SA 2.76 Million EUR -1090.734%
Quantum Genomics Société Anonyme 1.71 Million EUR -1816.337%
Sensorion SA 27.05 Million EUR -21.691%
Theranexus Société Anonyme 3 Million EUR -995.579%
TME Pharma N.V. 5.49 Million EUR -498.908%
Valbiotis SA 9.86 Million EUR -233.59%
TheraVet SA 1.64 Million EUR -1902.174%
Valerio Therapeutics Société anonyme 20.32 Million EUR -62.018%
DBV Technologies S.A. 89.4 Million EUR 63.177%
Genfit S.A. 54.8 Million EUR 39.928%
GeNeuro SA 14.35 Million EUR -129.305%
Innate Pharma S.A. 64.57 Million EUR 49.013%
Inventiva S.A. 120.18 Million EUR 72.607%
MaaT Pharma SA 21.59 Million EUR -52.431%
Nanobiotix S.A. 58.92 Million EUR 44.131%
OSE Immunotherapeutics SA 23.58 Million EUR -39.565%
Poxel S.A. 28.76 Million EUR -14.452%
GenSight Biologics S.A. 32.66 Million EUR -0.802%
Transgene SA 31.23 Million EUR -5.414%
Valneva SE 134.92 Million EUR 75.6%